24May
23May
Fishmeal substitute passes taste test
Sashimi derived from yellowtail fed a diet containing a novel fishmeal replacement has passed a consumer taste test with flying colours. The trial was conducted by KnipBio, a Massachusetts-based biotechnology company, along with its collaborator Kampachi Farms, and involved samples of yellowtail (Seriola rivoliana) that had been fed diets containing up to 7.5% of the microbe-derived KnipBio Meal (KBM). The trial was conducted at the Food Innovation Center at Oregon State University. Read more >>
23May
KnipBio’s Microbe Technology Creates Better Fish Feed
KnipBio, a Massachusetts-based biotechnology company, has developed a series of microbes that converts low-cost feedstocks into premium, nutritious, single-cell proteins that are an alternative to fishmeal in aquaculture. Its fermentation process yields a protein flour that is laden with immunity-boosting, pigment-enhancing carotenoids to produce healthier, more vibrant fish. Read more >>
19May
Chronix’s ASCO presentation abstract disclosure
Chronix Biomedical, Inc., a developer of novel blood-based cancer molecular diagnostics, notes the formal disclosure of the abstract covering its forthcoming presentation of its study in head and neck cancer at the American Society of Clinical Oncology ('ASCO') Annual Meeting on 5 June. Read more >>
19May
Paul Gudonis, CEO of Myomo, Talks IPO Launch and its MyoPro International Potential
INN had the chance to speak with Paul Gudonis, CEO of Myomo, about its lead product and IPO launch. Read more >>
18May
Regroup Mass Notification and Eagle Security Group to Present Webinar on Security for Houses of Worship
Regroup Mass Notification, the award-winning leader in emergency and day-to-day mass communication technology, will be presenting a free and informative webinar to focused on improving safety, security and emergency prevention strategies for houses of worship. Read more >>
18May
Premama strikes $4.5m investment to tackle pill fatigue in prenatal category
A cash injection upwards of $4.5m will help propel Premama into the forefront of non-pill prenatal nutrition, says president and founder Dan Aziz. Read more >>
16May
WBZ Radio with David Friend
A new company has been unveiled in Boston. It’s called Wasabi Technologies. Tune in >>
15May
Corbus Pharmaceuticals Gets a Buy Rating from Noble Financial
Corbus Pharmaceuticals Holdings, Inc. engages in the development and commercialization of novel therapeutics to treat rare or uncommon chronic and serious inflammatory and fibrotic diseases with clear unmet medical needs. Read more >>
12May